Powered by
InMed Pharmaceuticals falls for a second consecutive day, a two-day fall of 3.9% March 01, 2017 17:00 EST
Mar 1, 2017 - News Bites Canadian Markets


InMed Pharmaceuticals Inc. (CNSX:IN), Canada's 35th largest Biotechnology company by market cap, has fallen 0.50c (1.4%) for a second consecutive day on Wednesday. This brought its two-day fall to 1.50c (3.9%), compared with the S&P/TSX 60 Index which rose 6.3 points (0.7%) in the two days for a relative price change of -4.6%. The fall was exacerbated by a cumulative 2-day volume of 1.7 times average daily volume of 454,233 shares. The stock last traded at 36.50

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox
Related News Feeds

Mentioned Entities

See how you can reach these people and organizations